Gene discovery could pave way for nearsightedness treatments
September 13th, 2010 - 12:14 pm ICT by ANILondon, Sep 13 (ANI): Researchers at Duke University Medical Center have uncovered a gene linked with myopia or nearsightedness in Caucasian people from several different regions, including Dutch, British and Australian subjects.
The discovery could aid scientists to come up with new treatments for one of the most common eye disorder in the world.
Already, gene therapies are working well in some eye conditions, and myopia may be a good candidate condition for gene repair.
“The eye is already an organ of choice for gene therapy, for example, because the eye’s small volume and self-contained area allow the therapy to remain inside the eye in a concentrated volume,” Nature quoted lead author Dr. Terri Young as saying.
“In addition, the eye’s accessibility lets clinicians observe the effects of treatment over time with noninvasive methods that can illuminate and test the retina and other eye structures,” he added.
While many cases of myopia are mild, about 2 to 3 percent are pathological cases with retinal detachment, premature glaucoma, macular bleeding, and glaucoma leading eventually to blindness, said Young, who has spent over a decade studying the severe form of myopia.
Working with a large group of researchers, Young found several distinct spellings of DNA code near the RASGRF1 gene that had a strong association with focusing errors in vision.
These findings were validated in six other Caucasian adult groups in a total of 13,414 subjects.
“Because RASGRF1 is highly expressed in neurons and the retina, it is crucial to retinal function and visual memory consolidation,” said Young.
When the scientists created mice that were missing the correct gene, these mice showed changes in their eye lenses.
“This was biologically convincing. The RASGRF1 provides a novel molecular mechanism to study so that we can work to prevent the most common cause of visual impairment,” said Young.
Young has also led a team that found a different gene — CTNDD2 — related to myopia in Chinese and Japanese populations.
The study has been published in Nature Genetics. (ANI)
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Drug therapy shows promise in treating leading cause of childhood blindness - Feb 17, 2011
- Neoretina offers advanced surgery - Jan 19, 2012
- Obese women may be less likely to develop chronic eye disease - Feb 15, 2011
- Night blindness cured in mice with special cells - Apr 19, 2012
- Omega-3 in seafood may protect seniors' eyes - Dec 02, 2010
- Promising results of gene therapy to treat eye diseases - Aug 14, 2010
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Single shot of gene therapy could make kids with congenital blindness see - Oct 25, 2009
- Rogue gene causes short-sightedness - Sep 13, 2010
- New prosthetic device offers to hope to the visually impaired - Nov 19, 2010
- Novel way to prevent blindness caused by retinitis pigmentosa - Jun 12, 2010
- Breakthrough gene therapy could preserve vision - Aug 17, 2010
- Potential cure for vision diseases that lead to terminal blindness found - Aug 05, 2010
- Steroid injections offer 'vision restoration' hope for patients with blocked eye veins - Sep 15, 2009
Tags: adult groups, australian subjects, contained area, dna code, duke university medical, duke university medical center, eye disorder, eye lenses, eye structures, gene discovery, gene repair, gene therapies, memory consolidation, noninvasive methods, pathological cases, retinal detachment, retinal function, university medical center, visual memory, volume nature